CBD Life Sciences Inc (PK) (CBDL) Quote

This is going just like before last r/s. It is almost back to presplit .0001.To see people buying all the dilution shares. At any level is too much. All the management cares about is selling shares. They sold billions and billions since 2020. Yet revenues in 5 years are so tiny compared to the dilution. They got rich while shareholders have losses. Never changes here with this dilution scam.

What a winner you have here

How's this one doing now

What happened to this pump and dumper?Where are you hiding

When dilution here never ends. Never a good time to buy. Many thought the same before last r/s. Total loss. Just sad when people say this is a buy. The track record for 5 years says otherwise.

Good TIME TO BUY more
"Is CBDL stock a good investment?-- The CBD Life Sciences Inc. stock holds BUY signals from both
short and long-term
Moving Averages giving a positive forecast for the stock.

A lot of dilution today.

More dilution. Every day is.

I see so they have diluted it back to that much since r/s. At these prices tell us all. Who has millions of shares to sell? The company is who. When the next filing is made you will see it never stopped. Billions in dilution after last r/s. Sure it stopped lol. Sales under 1 million means so overvalued. .

O/S shares 40 days no change means no dilution

O/S 3.463,971,942 3/31/2025

O/S 3463,971,942 5.13/2025

Lies. At these levels who had this many shares to fill buys? Shareholders would be selling at a loss. It is called dilution. The company again has billions of a/s to sell after a r/s. It never ends. You just refuse to understand that has never changed. Wait for another filing, You will see. So far 100's of millions sold since the last r/s. Same as before as well. The management gets rich selling shares not under 1 million a year in CBD.

they stoped dilution for past 40 days.

You still refuse to see the record here. Dilution will never end. The revenues are tiny. If they did 10 times what was filed. Still tiny. Vs billions of shares in dilution before and after each r/s. They never state dollars for revenues because they are so small. They are a small player in a crowded CBD market. That is not changing. What does change is o/s shares filed going up. The company is filling suckers buys.

Good health products will sell fast,Revenue will increasing fast too. once PPS break out 0.0005 resistant, CBDL will run.

(May 6) CBD Life Sciences Inc. (CBDL) Announces New Manufacturing Deal
With A Southwest-Based Company 8:04 AM ET 5/6/25 | Dow Jones
Strategic alliance positions CBDL for aggressive national growth through 100+ retail locations and new premium product lines

-- CBD Life Sciences Inc. (OTC PINK:CBDL), a leading innovator in the CBD health and wellness space

-- a new strategic manufacturing partnership with Jeannie in a Bottle, a fast-growing Arizona-based CBD company with a national retail footprint.

-- Powerful collaboration will see CBDL formulating and manufacturing top-tier CBD products for Jeannie in a Bottle

-- a company with proven market traction and shelf presence in over 100 gas stations and convenience stores across the United States.

--The deal expands CBDL's manufacturing portfolio

-- opening the door to high-volume, recurring product orders

-- CBDL will take full control of the production, packaging, and labeling
of a specialized line of high-potency CBD products exclusively for Jeannie in a Bottle

--a strategic move expected to significantly boost CBDL's nationwide revenue stream
through consistent retail orders and brand expansion.

-- "This partnership is a win-win - not just for CBDL and Jeannie in a Bottle, but for shareholders and customers alike,"
said Lisa Nelson, President & CEO of CBD Life Sciences Inc. "We're stepping into a high-velocity retail environment
with a proven brand, and bringing our own formulation and production strengths to the table.
This is the kind of alignment that accelerates revenue, reputation, and results."

-- With CBDL managing product development, formulation, and manufacturing,
Jeannie in a Bottle is positioned to scale its product offerings faster than ever

-- offering convenience store customers across the country consistent, compliant,
and highly effective CBD wellness solutions.

Why This Deal Matters for CBDL Investors:

-- Built-In Distribution Power: Jeannie in a Bottle's existing footprint
includes over 100 retail stores nationwide - giving CBDL immediate access
to one of the most dynamic and accessible sales channels in the country.

-- Revenue Acceleration Potential: With consistent monthly reorders expected,
the deal strengthens CBDL's revenue pipeline through ongoing production
contracts and retail partnerships.

-- Brand Alignment & Synergy: Jeannie in a Bottle has a strong reputation
for customer satisfaction, quality products, and effective formulations -
values that align perfectly with CBDL's mission and vision.

-- Retail Momentum: The convenience store and gas station channel continues
to see increased demand for functional wellness products, with CBD
offerings leading the surge in consumer interest.

CBD Life Sciences Inc. continues to execute on its aggressive growth roadmap
through smart, synergistic partnerships like this one - pairing established retail
reach with premium product manufacturing to scale impact and revenue in tandem.
With more partnerships and product innovations on the horizon,
CBDL is positioning itself to be a national force in the CBD industry.

They see after 5 years how tiny revenues are vs dilution. They see in PR's they never state dollars because revenues are so l low. A 600% increase looks great until you realize even with that still under 1 million. They see the past dilution and r/s wiped out shareholders. They see it has happen multiple times the last 5 years. They see once again after a r/s it being diluted down to here. They see at these levels only the company selling new shares is filling buys. Yet fools think this time it will be different. Like before this r/s when it ends up at .0001. Will have more learn this is a dilution scam.

Dummies taking everything company says at face value without any proof.

No proof of profits, labs, or production.

$CBDL CBD $16 billion in sales in the United States. 2026

Good Morning $CBDL

You do realize that CBD as been around a long time now. There is a lot of competition. What do you think no matter what the volume is does not move much. She is running a dilution scam. She has sold so little in 5 years. except for billions of shares they have sold. Every time after one of their r/s. They start all over again diluting. Same as before. A/s same as before after the r/s billions. Nothing they have said has produced anything but tiny sales.

Door dash sales are up 220% $CBDL

"Mental health isn't a trend - it's a global crisis. And people are tired of band-aid solutions," said Lisa Nelson, President & CEO of CBD Life Sciences Inc. "This product was built to empower people who want to feel better and function better - without the side effects of traditional pharmaceuticals. It's a powerful, natural alternative that speaks directly to the stress, anxiety, and attention struggles millions face every day."

Petsmart is looking into our CBD pet products. Large revenue potential. $CBDL

The Armed Forces has an MOU in front of them for mushroom supplements. (Just waiting on signature)

Wrong. They have billions of shares to sell. The company is filling buys at these levels. All they care about is selling shares. It has been that way for the last 5 years of non stop dilution and r/s's.

Pets Petsmart is looking into our CBD pet products. Large revenue potential. $CBDL

The Armed Forces has an MOU in front of them for mushroom supplements. (Just waiting on signature)

Door dash sales are up 220%— CBD Life Sciences Inc. $CBDL (@CBDL_StockOTC) May 8, 2025

only 9mm shares at ask 0.0005, It may gone today

Smart CEO, time to begin buy back at 0.0005 cheap now, if you want PPS going up!!!!!

2 weeks away with our smoothie bar. $CBDL

$CBDL is manufacturing a new stronger sleep mushroom product.

2 weeks away with our smoothie bar.

Poor scammers can't save the sinking shift

Online sales up 620% now and growing. Revenue from manufacturing deals coming.

Health & Wellness event in Scottsdale next weekend.

Waiting on Sprouts Groucery Market for our CBD & Mushroom products to put on shelves.

Good Morning $CBDL

Wrong. Just keep ignoring the buys being filled by dilution. No one has gains to sell millions a day at these levels. The company has billions to sell. This is no different then before the last r/s. They are lying if saying no more dilution. They are only one with millions of shares to fill buys to new suckers.

So close to breaking out! $CBDL

At these levels who filling the buys? The dilution shares. As for another r/s. Sure I doubt it be approved. Big news? Say revenues are up 600%. When that is 167,000 x 6. Still tiny. There is no big news. They never state revenue $'s do they.

$CBDL Mushroom Madness Website: mushroommadness.shop

We get positively glowing updates at least weekly, and this stock cannot lift itself off the bottom.
Why? Does anyone have a clue or a constructive opinion?
"We have zero debt on the books, and we believe that with the current revenue coming in that our share price can drastically rise." I think dramatically would be a better word choice than drastically when referring to share price.

but who are selling at 0.0004????

"We haven’t issued any stock in over a month. Again there is never going to be another reverse split.

We have zero debt on the books and we believe that with the current revenue coming in that our share price can drastically rise.

Big news is coming tomorrow."

Why today"s PPS down 20%? Unbelievable sell????

Good morning! Mushroom pouches is our new product. $CBDL

Online sales up 620% now and growing. Revenue from manufacturing deals coming.

Health & Wellness event in Scottsdale next weekend.

Waiting on Sprouts Groucery Market for our CBD & Mushroom products to put on shelves.— CBD Life Sciences Inc. $CBDL (@CBDL_StockOTC) May 7, 2025

Good Morning $CBDL

"This partnership is a win-win - not just for CBDL and Jeannie in a Bottle, but for shareholders and customers alike," said Lisa Nelson, President & CEO of CBD Life Sciences Inc. "We're stepping into a high-velocity retail environment with a proven brand, and bringing our own formulation and production strengths to the table. This is the kind of alignment that accelerates revenue, reputation, and results."

With CBDL managing product development, formulation, and manufacturing, Jeannie in a Bottle is positioned to scale its product offerings faster than ever - offering convenience store customers across the country consistent, compliant, and highly effective CBD wellness solutions.

Why This Deal Matters for CBDL Investors: $$

There is an endless supply of new shares. Until they max out the billions of a/s. The company dilution shares are filling the buys at these levels. This is not new. Same before every r/s. and after. Before the last r/s. It did the same as is has been since this last one.

CBD Life Sciences Inc. (CBDL) Announces New Manufacturing Deal With A Southwest-Based Company

Strategic alliance positions CBDL for aggressive national growth through 100+ retail locations and new premium product lines

SCOTTSDALE, AZ / ACCESS Newswire / May 6, 2025 / CBD Life Sciences Inc. (OTC PINK:CBDL), a leading innovator in the CBD health and wellness space, is proud to announce a new strategic manufacturing partnership with Jeannie in a Bottle, a fast-growing Arizona-based CBD company with a national retail footprint.

This powerful collaboration will see CBDL formulating and manufacturing top-tier CBD products for Jeannie in a Bottle - a company with proven market traction and shelf presence in over 100 gas stations and convenience stores across the United States. The deal expands CBDL's manufacturing portfolio while opening the door to high-volume, recurring product orders tied to Jeannie's established consumer base and retail distribution network. Under this agreement, CBDL will take full control of the production, packaging, and labeling of a specialized line of high-potency CBD products exclusively for Jeannie in a Bottle - a strategic move expected to significantly boost CBDL's nationwide revenue stream through consistent retail orders and brand expansion.

"This partnership is a win-win - not just for CBDL and Jeannie in a Bottle, but for shareholders and customers alike," said Lisa Nelson, President & CEO of CBD Life Sciences Inc. "We're stepping into a high-velocity retail environment with a proven brand, and bringing our own formulation and production strengths to the table. This is the kind of alignment that accelerates revenue, reputation, and results."

With CBDL managing product development, formulation, and manufacturing, Jeannie in a Bottle is positioned to scale its product offerings faster than ever - offering convenience store customers across the country consistent, compliant, and highly effective CBD wellness solutions.

Why This Deal Matters for CBDL Investors:

Built-In Distribution Power: Jeannie in a Bottle's existing footprint includes over 100 retail stores nationwide - giving CBDL immediate access to one of the most dynamic and accessible sales channels in the country.
Revenue Acceleration Potential: With consistent monthly reorders expected, the deal strengthens CBDL's revenue pipeline through ongoing production contracts and retail partnerships.
Brand Alignment & Synergy: Jeannie in a Bottle has a strong reputation for customer satisfaction, quality products, and effective formulations - values that align perfectly with CBDL's mission and vision.
Retail Momentum: The convenience store and gas station channel continues to see increased demand for functional wellness products, with CBD offerings leading the surge in consumer interest.

CBD Life Sciences Inc. continues to execute on its aggressive growth roadmap through smart, synergistic partnerships like this one - pairing established retail reach with premium product manufacturing to scale impact and revenue in tandem. With more partnerships and product innovations on the horizon, CBDL is positioning itself to be a national force in the CBD industry.
https://app.accessnewswire.com/imagelibrary/777c7b6f-2c66-4ff1-8923-598c91355c36/1023843/cbd.jpg

About CBD Life Sciences Inc. (CBDL):
CBD Life Sciences Inc. is a publicly traded company focused on the development and marketing of high-quality, science-backed CBD wellness products. Through strategic partnerships and proprietary manufacturing, CBDL continues to expand its footprint across health, retail, and nutraceutical markets nationwide. For more information, visit https://thecbdvault.com/

About Jeannie in a Bottle:
Based in Arizona, Jeannie in a Bottle is a rising CBD brand with a nationwide footprint, delivering high-quality CBD products through an expanding network of convenience stores and gas stations. Known for its effective formulations and loyal customer base, the company is committed to bringing accessible wellness solutions to everyday consumers.

Follow our social media for the latest updates!
X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
IR Contact: cbdvaultaz@gmail.com

Stay Connected & Be the First to Try Our New Functional Mushroom Products!

Mushroom Madness Instagram: https://www.instagram.com/mushroom.madnessaz

Mushroom Madness Website: https://www.mushroommadness.shop

Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.

Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.

Contact Information
Lisa Nelson
CEO
cbdvaultaz@gmail.com
4802091720

SOURCE: CBD Life Sciences, Inc.


View the original press release on ACCESS Newswire

https://app.accessnewswire.com/img.ashx?id=1023843
https://www.otcmarkets.com/stock/CBDL/news/CBD-Life-Sciences-Inc-CBDL-Announces-New-Manufacturing-Deal-With-A-Southwest-Based-Company?id=476213
© Copyright 2025 ACCESS Newswire. All Rights Reserved.

Scam master Jack!

Good morning $CBDL we’re excited to announce a new manufacturing deal!

This deal will bring in huge revenue from the high volume recurring orders as their products are in 100+ locations.

We now have national and international manufacturing deals! https://t.co/c54Dglq8X6— CBD Life Sciences Inc. $CBDL (@CBDL_StockOTC) May 6, 2025

Not many 5's left.. I think if 5's go we can run hard

Excellent news out $CBDL

Built-In Distribution Power: Jeannie in a Bottle's existing footprint includes over 100 retail stores nationwide - giving CBDL immediate access to one of the most dynamic and accessible sales channels in the country.

Revenue Acceleration Potential: With consistent monthly reorders expected, the deal strengthens CBDL's revenue pipeline through ongoing production contracts and retail partnerships.

Brand Alignment & Synergy: Jeannie in a Bottle has a strong reputation for customer satisfaction, quality products, and effective formulations - values that align perfectly with CBDL's mission and vision.

Retail Momentum: The convenience store and gas station channel continues to see increased demand for functional wellness products, with CBD offerings leading the surge in consumer interest.

CBD Life Sciences Inc. continues to execute on its aggressive growth roadmap through smart, synergistic partnerships like this one - pairing established retail reach with premium product manufacturing to scale impact and revenue in tandem. With more partnerships and product innovations on the horizon, CBDL is positioning itself to be a national force in the CBD industry.